Feb 13 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to two online vendors for selling unapproved and misbranded versions of semaglutide and tirzepatide ...
Warnings have been issued over fake weight loss jabs that could be “life-threatening” after thousands of fraudulent online pharmacies were uncovered. Fake versions of Ozempic, a popular brand of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback